314 related articles for article (PubMed ID: 28699397)
41. Molecular Imaging of Therapeutic Effect of Mesenchymal Stem Cell-Derived Exosomes for Hindlimb Ischemia Treatment.
Zhang K; Li Z
Methods Mol Biol; 2020; 2150():213-225. PubMed ID: 30941719
[TBL] [Abstract][Full Text] [Related]
42. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2.
Cao R; Bråkenhielm E; Pawliuk R; Wariaro D; Post MJ; Wahlberg E; Leboulch P; Cao Y
Nat Med; 2003 May; 9(5):604-13. PubMed ID: 12669032
[TBL] [Abstract][Full Text] [Related]
43. Enhanced proangiogenic potential of mesenchymal stem cell-derived exosomes stimulated by a nitric oxide releasing polymer.
Du W; Zhang K; Zhang S; Wang R; Nie Y; Tao H; Han Z; Liang L; Wang D; Liu J; Liu N; Han Z; Kong D; Zhao Q; Li Z
Biomaterials; 2017 Jul; 133():70-81. PubMed ID: 28433939
[TBL] [Abstract][Full Text] [Related]
44. Highly angiogenic CXCR4(+)CD31(+) monocyte subset derived from 3D culture of human peripheral blood.
Hur J; Choi JI; Yun JY; Yoon CH; Jang JH; Im SG; Ko SB; Kang JA; Park J; Lee SE; Kim JY; Yang HM; Park YB; Kim HS
Biomaterials; 2013 Mar; 34(8):1929-41. PubMed ID: 23267826
[TBL] [Abstract][Full Text] [Related]
45. Exosomes secreted by mesenchymal stem cells promote endothelial cell angiogenesis by transferring miR-125a.
Liang X; Zhang L; Wang S; Han Q; Zhao RC
J Cell Sci; 2016 Jun; 129(11):2182-9. PubMed ID: 27252357
[TBL] [Abstract][Full Text] [Related]
46. Sourcing of an alternative pericyte-like cell type from peripheral blood in clinically relevant numbers for therapeutic angiogenic applications.
Blocki A; Wang Y; Koch M; Goralczyk A; Beyer S; Agarwal N; Lee M; Moonshi S; Dewavrin JY; Peh P; Schwarz H; Bhakoo K; Raghunath M
Mol Ther; 2015 Mar; 23(3):510-22. PubMed ID: 25582709
[TBL] [Abstract][Full Text] [Related]
47. Synergistic angiogenic effect of codelivering fibroblast growth factor 2 and granulocyte-colony stimulating factor from fibrin scaffolds and bone marrow transplantation in critical limb ischemia.
Layman H; Rahnemai-Azar AA; Pham SM; Tsechpenakis G; Andreopoulos FM
Tissue Eng Part A; 2011 Jan; 17(1-2):243-54. PubMed ID: 20712534
[TBL] [Abstract][Full Text] [Related]
48. Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease.
Schellinger IN; Cordasic N; Panesar J; Buchholz B; Jacobi J; Hartner A; Klanke B; Jakubiczka-Smorag J; Burzlaff N; Heinze E; Warnecke C; Raaz U; Willam C; Tsao PS; Eckardt KU; Amann K; Hilgers KF
Kidney Int; 2017 Mar; 91(3):616-627. PubMed ID: 27927598
[TBL] [Abstract][Full Text] [Related]
49. miR-342-5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling.
Yan XC; Cao J; Liang L; Wang L; Gao F; Yang ZY; Duan JL; Chang TF; Deng SM; Liu Y; Dou GR; Zhang J; Zheng QJ; Zhang P; Han H
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857067
[TBL] [Abstract][Full Text] [Related]
50. Ameliorating effects of Cuscuta chinensis Lamak extract on hind‑limb ischemia, and angiogenic‑ or inflammatory associated factors in ovariectomized mice.
Kim HJ; Yang H; Jung DH; Hwang JT; Ko BS
Mol Med Rep; 2019 Apr; 19(4):3321-3329. PubMed ID: 30816501
[TBL] [Abstract][Full Text] [Related]
51. An injectable elastin-based gene delivery platform for dose-dependent modulation of angiogenesis and inflammation for critical limb ischemia.
Dash BC; Thomas D; Monaghan M; Carroll O; Chen X; Woodhouse K; O'Brien T; Pandit A
Biomaterials; 2015 Oct; 65():126-39. PubMed ID: 26151745
[TBL] [Abstract][Full Text] [Related]
52. Nanoparticular delivery system for a secretoneurin derivative induces angiogenesis in a hind limb ischemia model.
Albrecht-Schgoer K; Barthelmes J; Schgoer W; Theurl M; Nardin I; Lener D; Gutmann C; Dünnhaupt S; Bernkop-Schnürch A; Kirchmair R
J Control Release; 2017 Mar; 250():1-8. PubMed ID: 28167285
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of fragmin/protamine microparticles containing fibroblast growth factor-2 (F/P MPs/FGF-2) to induce collateral vessels in a rabbit model of hindlimb ischemia.
Horio T; Fujita M; Tanaka Y; Ishihara M; Kishimoto S; Nakamura S; Hase K; Maehara T
J Vasc Surg; 2011 Sep; 54(3):791-8. PubMed ID: 21620612
[TBL] [Abstract][Full Text] [Related]
54. The anti-angiogenic effect of atorvastatin loaded exosomes on glioblastoma tumor cells: An in vitro 3D culture model.
Valipour E; Ranjbar FE; Mousavi M; Ai J; Malekshahi ZV; Mokhberian N; Taghdiri-Nooshabadi Z; Khanmohammadi M; Nooshabadi VT
Microvasc Res; 2022 Sep; 143():104385. PubMed ID: 35609635
[TBL] [Abstract][Full Text] [Related]
55. The endothelial cell secretome as a novel treatment to prime adipose-derived stem cells for improved wound healing in diabetes.
Fromer MW; Chang S; Hagaman ALR; Koko KR; Nolan RS; Zhang P; Brown SA; Carpenter JP; Caputo FJ
J Vasc Surg; 2018 Jul; 68(1):234-244. PubMed ID: 28760584
[TBL] [Abstract][Full Text] [Related]
56. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
[TBL] [Abstract][Full Text] [Related]
57. Horizontal transfer of miR-23a from hypoxic tumor cell colonies can induce angiogenesis.
Sruthi TV; Edatt L; Raji GR; Kunhiraman H; Shankar SS; Shankar V; Ramachandran V; Poyyakkara A; Kumar SVB
J Cell Physiol; 2018 Apr; 233(4):3498-3514. PubMed ID: 28929578
[TBL] [Abstract][Full Text] [Related]
58. Coadministration of adipose-derived stem cells and control-released basic fibroblast growth factor facilitates angiogenesis in a murine ischemic hind limb model.
Horikoshi-Ishihara H; Tobita M; Tajima S; Tanaka R; Oshita T; Tabata Y; Mizuno H
J Vasc Surg; 2016 Dec; 64(6):1825-1834.e1. PubMed ID: 26597457
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
60. Overcoming disease-induced growth factor resistance in therapeutic angiogenesis using recombinant co-receptors delivered by a liposomal system.
Das S; Singh G; Baker AB
Biomaterials; 2014 Jan; 35(1):196-205. PubMed ID: 24138828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
